The Care Ledger

Daily edition Tuesday, November 17, 2026

Search
Tuesday, November 17, 2026Today's Paper From the publisher Free hospital price search Published bysoro
The Care Ledger

Daily edition

Tuesday, November 17, 2026

Everything The Care Ledger published that day: 1 story, the news in brief and the figures.

  • 01

    CMS proposes an anti-fraud rule it says would save nearly $90 billion

    The Centers for Medicare & Medicaid Services (CMS) said the rule would save nearly $90 billion over 10 years across Medicare, Medicaid, CHIP and the marketplace, in part by tightening Medicare Advantage audits of diagnoses that medical records do not support. Comments are due January 19, 2027.

    CMS

  • 02

    Medicaid's improper payment rate rose to 7.08%

    CMS estimates $46.84 billion in improper Medicaid payments in fiscal 2026, up from $37.39 billion, and a rate of 7.32% in traditional Medicare. CMS notes that improper payments are not a measure of fraud.

    CMS

  • 03

    52% of nonprofit hospitals got more in tax breaks than they gave back, Lown finds

    The Lown Institute put the net gap at $15.5 billion for fiscal 2023 across more than 3,000 hospitals. Mayo Clinic's Rochester hospital had the largest gap, about $366 million, MPR News reported; Mayo disputes the method.

    Lown Institute

  • 04

    Minnesota will not block Sutter Health's takeover of Allina Health

    Attorney General Keith Ellison agreed to 10 years of oversight, and Sutter committed $2.15 billion over five years.

    MPR News

  1. $274

    Maryland's payment limit for a 30-day supply of Ozempic from January 2027, matching Medicare's negotiated price

    Maryland finalizes the first state payment limits on a drug, for Ozempic and Jardiance

  2. $204

    the limit for a 30-day supply of Jardiance, or $6.80 a pill

    Maryland finalizes the first state payment limits on a drug, for Ozempic and Jardiance

  3. $5.8million

    estimated yearly savings for government plans on Ozempic, rising to $113 million to $165 million if all Maryland plans were covered

    Maryland finalizes the first state payment limits on a drug, for Ozempic and Jardiance

  4. 2028

    the year a 2025 law lets the board extend limits to private insurance

    Maryland finalizes the first state payment limits on a drug, for Ozempic and Jardiance